Contribution of endogenous G-protein-coupled receptor kinases to Ser129 phosphorylation of alpha-synuclein in HEK293 cells
- PMID: 19410557
- DOI: 10.1016/j.bbrc.2009.04.130
Contribution of endogenous G-protein-coupled receptor kinases to Ser129 phosphorylation of alpha-synuclein in HEK293 cells
Abstract
The majority of alpha-synuclein (alphaS) deposited in Lewy bodies, the pathological hallmark of Parkinson's disease (PD), is phosphorylated at serine 129 (Ser129). Ser129 phosphorylation of alphaS has been demonstrated to enhance the alphaS toxicity to dopaminergic neurons in a Drosophila model of PD. Phosphorylation of alphaS at Ser129 seems to play a crucial role in the pathogenesis of PD. Here, we assessed the contribution of ubiquitously expressing members of the G-protein-coupled receptor kinase family (GRK2, GRK3, GRK5, and GRK6) to Ser129 phosphorylation of alphaS in HEK293 cells. To selectively reduce the endogenous expression of each member of the GRK family in cells, we used small interfering RNAs. Knockdown of GRK3 or GRK6 significantly decreased Ser129 phosphorylation of alphaS; however, knockdown of GRK2 or GRK5 did not decrease alphaS phosphorylation. The results indicate that endogenous GRK3 and GRK6, but not GRK2 or GRK5, contribute to Ser129 phosphorylation of alphaS in HEK293 cells.
Similar articles
-
In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain.Neuroscience. 2014 Jan 3;256:72-82. doi: 10.1016/j.neuroscience.2013.09.061. Epub 2013 Oct 12. Neuroscience. 2014. PMID: 24128992
-
N-terminal region of alpha-synuclein is essential for the fatty acid-induced oligomerization of the molecules.FEBS Lett. 2008 Oct 29;582(25-26):3693-700. doi: 10.1016/j.febslet.2008.10.001. Epub 2008 Oct 9. FEBS Lett. 2008. PMID: 18848547
-
G protein-coupled receptor kinase 5, overexpressed in the alpha-synuclein up-regulation model of Parkinson's disease, regulates bcl-2 expression.Brain Res. 2010 Jan 11;1307:134-41. doi: 10.1016/j.brainres.2009.10.036. Epub 2009 Oct 21. Brain Res. 2010. PMID: 19852948
-
The role of Ser129 phosphorylation of α-synuclein in neurodegeneration of Parkinson's disease: a review of in vivo models.Rev Neurosci. 2013;24(2):115-23. doi: 10.1515/revneuro-2012-0071. Rev Neurosci. 2013. PMID: 23314528 Review.
-
α-Synuclein phosphorylation as a therapeutic target in Parkinson's disease.Rev Neurosci. 2012 Mar 21;23(2):191-8. doi: 10.1515/revneuro-2011-0067. Rev Neurosci. 2012. PMID: 22499677 Review.
Cited by
-
Suppression of α-synuclein toxicity and vesicle trafficking defects by phosphorylation at S129 in yeast depends on genetic context.Hum Mol Genet. 2012 Jun 1;21(11):2432-49. doi: 10.1093/hmg/dds058. Epub 2012 Feb 21. Hum Mol Genet. 2012. PMID: 22357655 Free PMC article.
-
Serine 129 phosphorylation of membrane-associated α-synuclein modulates dopamine transporter function in a G protein-coupled receptor kinase-dependent manner.Mol Biol Cell. 2013 Jun;24(11):1649-60, S1-3. doi: 10.1091/mbc.E12-12-0903. Epub 2013 Apr 10. Mol Biol Cell. 2013. PMID: 23576548 Free PMC article.
-
Genetic deletion of Polo-like kinase 2 reduces alpha-synuclein serine-129 phosphorylation in presynaptic terminals but not Lewy bodies.J Biol Chem. 2021 Jan-Jun;296:100273. doi: 10.1016/j.jbc.2021.100273. Epub 2021 Jan 9. J Biol Chem. 2021. PMID: 33428941 Free PMC article.
-
Proteomics Challenges for the Assessment of Synuclein Proteoforms as Clinical Biomarkers in Parkinson's Disease.Front Aging Neurosci. 2022 Mar 31;14:818606. doi: 10.3389/fnagi.2022.818606. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35431896 Free PMC article. Review.
-
Interplay between sumoylation and phosphorylation for protection against α-synuclein inclusions.J Biol Chem. 2014 Nov 7;289(45):31224-40. doi: 10.1074/jbc.M114.559237. Epub 2014 Sep 17. J Biol Chem. 2014. PMID: 25231978 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases